GSK on Wednesday said it was "well positioned" to absorb potential U.S. pharmaceutical tariffs, citing AI-driven cost cuts ...

GSK said it remains confident in its ability to absorb the financial impact of potential US pharmaceutical tariffs as it ...

British drugmaker GSK insisted it was “well positioned” to respond to the impact of sector-specific tariffs amid widespread ...

U.S.-listed shares of GSK are gaining in intraday trading Wednesday after the British pharma giant posted ...

As GSK weathers the storm of sinking vaccine sales and gears up for key launches in its specialty medicines sector, the ...

WEDNESDAY, April 30, 2025 (HealthDay News) — More children stopped using steroid inhalers to control their asthma after a ...

GSK scored highly as its R&D programmes ... AbbVie is hoping to extend its range of neurotoxin-based pharma and cosmetic products with a short-acting successor to its blockbuster Botox brand.

Trump administration probing extent to which pharmaceutical imports may threaten national security, a likely prelude to imposing tariffs ...

The UK's Medicines and Healthcare products Regulatory Agency (MHRA) has authorised GSK’s Blenrep for treating multiple ...

U.K. regulators cleared a multiple myeloma drug GSK withdrew from market three years ago. Elsewhere, RNA editing startup Airna tapped a former Sarepta executive to oversee its pipeline.

GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the ...